The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.
Alok A KhoranaKeith McCraeDejan MilentijevicNora McCormickFrançois LalibertéConcetta CriveraPatrick LefebvreDominique LejeuneHeather RozjabekJeff ScheinMichael B StreiffPublished in: American journal of hematology (2018)